Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
jtFnGv6SF3TWBnPw
Listen
